Study of ASN-002 to Treat Basal Cell Carcinomas (BCCs) in Individuals With Basal Cell Nevus Syndrome (BCNS)

Clinical trial NCT03208296 · SUSPENDED

Trial details

NCT number: NCT03208296
Sponsor: Ascend Biopharmaceuticals Ltd
Status: SUSPENDED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Basal Cell Carcinoma in Basal Cell Nevus Syndrome

Start date: 2017-12-01
Primary completion: 2024-12-31
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.